These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7713956)

  • 21. Resorbable glass-ceramic phosphate-based scaffolds for bone tissue engineering: synthesis, properties, and in vitro effects on human marrow stromal cells.
    Vitale-Brovarone C; Ciapetti G; Leonardi E; Baldini N; Bretcanu O; Verné E; Baino F
    J Biomater Appl; 2011 Nov; 26(4):465-89. PubMed ID: 20566654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the effect of germanium on the structure of SiO
    Mokhtari S; Krull EA; Sanders LM; Coughlan A; Mellott NP; Gong Y; Borges R; Wren AW
    Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109843. PubMed ID: 31349461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes of cement properties caused by mixing errors: the therapeutic range of different cement types.
    Behr M; Rosentritt M; Loher H; Kolbeck C; Trempler C; Stemplinger B; Kopzon V; Handel G
    Dent Mater; 2008 Sep; 24(9):1187-93. PubMed ID: 18372038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioactivity of gel-glass powders in the CaO-SiO2 system: a comparison with ternary (CaO-P2O5-SiO2) and quaternary glasses (SiO2-CaO-P2O5-Na2O).
    Saravanapavan P; Jones JR; Pryce RS; Hench LL
    J Biomed Mater Res A; 2003 Jul; 66(1):110-9. PubMed ID: 12833437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of incorporation of HA/ZrO(2) into glass ionomer cement (GIC).
    Gu YW; Yap AU; Cheang P; Khor KA
    Biomaterials; 2005 Mar; 26(7):713-20. PubMed ID: 15350775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro biocompatibility of a novel Fe2O3 based glass ionomer cement.
    Hurrell-Gillingham K; Reaney IM; Brook I; Hatton PV
    J Dent; 2006 Sep; 34(8):533-8. PubMed ID: 16530912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bioactive sol-gel glass added ionomer cement for the regeneration of tooth structure.
    Choi JY; Lee HH; Kim HW
    J Mater Sci Mater Med; 2008 Oct; 19(10):3287-94. PubMed ID: 18483787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium sulphate-based cements containing cephalexin.
    Doadrio JC; Arcos D; Cabañas MV; Vallet-Regí M
    Biomaterials; 2004 Jun; 25(13):2629-35. PubMed ID: 14751749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new bioactive bone cement consisting of BIS-GMA resin and bioactive glass powder.
    Kawanabe K; Tamura J; Yamamuro T; Nakamura T; Kokubo T; Yoshihara S
    J Appl Biomater; 1993; 4(2):135-41. PubMed ID: 10148600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of glass composition on the properties of glass polyalkenoate cements. Part II: influence of phosphate content.
    Griffin SG; Hill RG
    Biomaterials; 2000 Feb; 21(4):399-403. PubMed ID: 10656322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zinc ion release from novel hard tissue biomaterials.
    Towler MR; Kenny S; Boyd D; Pembroke T; Buggy M; Hill RG
    Biomed Mater Eng; 2004; 14(4):565-72. PubMed ID: 15472403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel skeletal drug delivery system using self-setting calcium phosphate cement. 9: Effects of the mixing solution volume on anticancer drug release from homogeneous drug-loaded cement.
    Otsuka M; Matsuda Y; Fox JL; Higuchi WI
    J Pharm Sci; 1995 Jun; 84(6):733-6. PubMed ID: 7562414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel skeletal drug delivery system for anti-bacterial drugs using self-setting hydroxyapatite cement.
    Otsuka M; Matsuda Y; Yu D; Wong J; Fox JL; Higuchi WI
    Chem Pharm Bull (Tokyo); 1990 Dec; 38(12):3500-2. PubMed ID: 2092949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of fluoride release from hydroxyapatite incorporated and conventional glass ionomer cement: an in vitro study.
    Tiwari S; Nandlal B
    J Indian Soc Pedod Prev Dent; 2012; 30(4):284-7. PubMed ID: 23514678
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced apatite-forming ability and antibacterial activity of porous anodic alumina embedded with CaO-SiO2-Ag2O bioactive materials.
    Ni S; Li X; Yang P; Ni S; Hong F; Webster TJ
    Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():700-8. PubMed ID: 26478362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoride-containing bioactive glasses: effect of glass design and structure on degradation, pH and apatite formation in simulated body fluid.
    Brauer DS; Karpukhina N; O'Donnell MD; Law RV; Hill RG
    Acta Biomater; 2010 Aug; 6(8):3275-82. PubMed ID: 20132911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRIS buffer in simulated body fluid distorts the assessment of glass-ceramic scaffold bioactivity.
    Rohanová D; Boccaccini AR; Yunos DM; Horkavcová D; Březovská I; Helebrant A
    Acta Biomater; 2011 Jun; 7(6):2623-30. PubMed ID: 21345388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gentamicin-loaded hydraulic calcium phosphate bone cement as antibiotic delivery system.
    Bohner M; Lemaître J; Van Landuyt P; Zambelli PY; Merkle HP; Gander B
    J Pharm Sci; 1997 May; 86(5):565-72. PubMed ID: 9145380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of geometrical cement size on in vitro and in vivo indomethacin release from self-setting apatite cement.
    Otsuka M; Nakahigashi Y; Matsuda Y; Fox JL; Higuchi WI; Sugiyama Y
    J Control Release; 1998 Mar; 52(3):281-9. PubMed ID: 9743448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cobalt-releasing 1393 bioactive glass-derived scaffolds for bone tissue engineering applications.
    Hoppe A; Jokic B; Janackovic D; Fey T; Greil P; Romeis S; Schmidt J; Peukert W; Lao J; Jallot E; Boccaccini AR
    ACS Appl Mater Interfaces; 2014 Feb; 6(4):2865-77. PubMed ID: 24476347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.